Selected Publications:

Seminario-Vidal L, Kroshinsky D, Malachowski SJ, et al. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. Journal of the American Academy of Dermatology. 2020.

Noe MH, Rosenbach M, Hubbard RA, et al. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10. JAMA dermatology. 2019;155(4):448-454.

Noe MH, Micheletti RG, Mostaghimi A. Timing of mucocutaneous symptoms and medication discontinuation in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. Journal of the American Academy of Dermatology. 2019;81(6):1410-1412.

Noe MH, Mostaghimi A, Rosenbach M, Shinkai K, Micheletti RG. Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors. The Journal of investigative dermatology. 2018;138(9):2068-2072.

Micheletti RG, Chiesa-Fuxench Z, Noe MH, et al. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. The Journal of investigative dermatology. 2018;138(11):2315-2321.

Li DG, Thomas C, Weintraub GS, Mostaghimi A. Symmetrical Drug-related Intertriginous and Flexural Exanthema Induced by Doxycycline. Cureus. 2017;9(11):e1836.